470 results on '"Girardi, G."'
Search Results
202. The Intersection of Maternal Metabolic Syndrome, Adverse Pregnancy Outcomes, and Future Metabolic Health for the Mother and Offspring.
- Author
-
Girardi G and Bremer AA
- Subjects
- Female, Humans, Mothers, Obesity complications, Obesity epidemiology, Obesity therapy, Pregnancy, Pregnancy Outcome epidemiology, Risk Factors, Diabetes, Gestational, Metabolic Syndrome complications, Metabolic Syndrome diagnosis, Metabolic Syndrome epidemiology, Pregnancy Complications diagnosis, Pregnancy Complications epidemiology
- Abstract
The prevalence of obesity is ∼40% in the United States, and the prepregnancy prevalence of obesity in females is ∼30%. This has in part fueled an increase in metabolic syndrome (MetS) among females who are currently pregnant, have been pregnant, or are planning to become pregnant. Importantly, MetS in pregnancy is associated with increased pregnancy complications. Moreover, MetS in pregnancy may have long-lasting adverse cardiovascular and metabolic health implications for the mother and her offspring. To complicate matters, many adverse pregnancy outcomes seem to increase the risk of MetS in the mother after pregnancy. Herein, we describe the potential mechanisms behind the intersection of MetS, adverse pregnancy outcomes, and subsequent long-term disease in the mother and offspring. Because MetS is a cluster of coexisting conditions, it is challenging to identify mediators that can serve as biomarkers for early diagnosis and targets for MetS prevention and therapy.
- Published
- 2022
- Full Text
- View/download PDF
203. Six Month Interim Outcomes from SECURE: A Single arm, Multicenter, Prospective, Clinical Study on a Novel Minimally Invasive Posterior Sacroiliac Fusion Device.
- Author
-
Calodney AK, Azeem N, Buchanan P, Skaribas I, Antony A, Kim C, Girardi G, Vu C, Bovinet C, Vogel RS, Li S, Jassal N, Josephson Y, Lubenow TR, Girardi N, and Pope JE
- Subjects
- Humans, Pain Measurement, Prospective Studies, Sacroiliac Joint surgery, Treatment Outcome, Low Back Pain diagnosis, Low Back Pain surgery, Spinal Fusion methods
- Abstract
Introduction: Sacroiliac joint disease is a prominent diagnosis across the world. A novel fixation technique employing a posterior approach, single point, bone allograft transfixation has proven to be helpful anecdotally. The purpose of this is study is to investigate prospectively the safety and efficacy of this approach., Methods: A multicenter, prospective, single arm study was performed after patient identification and treatment with the novel posterior fusion, single-point transfixation system and followed for 24 months. Target enrollment is 100 patients. Interim results on the first 69 consecutive patients at 6 months is presented. Primary endpoint at 6-month analysis was Pain Intensity reduction by visual analogue scale and functional improvement by Oswestry Disability Index. Adverse events were assessed for safety analysis., Results: In total, 69 patients were identified for this analysis. At 6 months, a mean improvement of 34.9 was identified by a reduction in VAS and functional improvement was demonstrated by a mean reduction in ODI of 17.7. There were three adverse events, all unrelated to the device., Conclusion: The posterior single point transfixation is safe and efficacious for the treatment of sacroiliac joint dysfunction with statistical improvements in pain and function.
- Published
- 2022
- Full Text
- View/download PDF
204. Advancing research on recurrent pregnancy loss: Overcoming obstacles and opportunities for translation.
- Author
-
Girardi G and Bremer AA
- Subjects
- Abortion, Habitual pathology, Animals, Female, Humans, Pregnancy, Risk Factors, Abortion, Habitual etiology, Uterus pathology
- Abstract
Recurrent pregnancy loss (RPL) is one of the most complex and challenging scenarios in reproductive medicine. New theories about the mechanisms behind RPL have recently emerged, highlighting the multifactorial nature of this serious pregnancy complication. Unfortunately, these preclinical observations are rarely validated in the human scenario, where treatment remains ineffective and empirical. New technologies such as organoids, organ-on-a-chip, and 3D printing can be used to characterize the molecular cross talk between the uterine environment with its unique inflammatory cells and the developing embryo. Understanding the mechanisms behind RPL and identifying mediators and effectors and validating these targets for prevention and therapy in humans will have a profound impact on women's health., (© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2022
- Full Text
- View/download PDF
205. Scientific Evidence Supporting Coronavirus Disease 2019 (COVID-19) Vaccine Efficacy and Safety in People Planning to Conceive or Who Are Pregnant or Lactating.
- Author
-
Girardi G and Bremer AA
- Subjects
- Adolescent, Adult, Female, Humans, Lactation, Pregnancy, Young Adult, COVID-19 prevention & control, COVID-19 Vaccines administration & dosage, Preconception Care, Pregnancy Complications, Infectious prevention & control, Prenatal Care, Puerperal Infection prevention & control, SARS-CoV-2, Vaccine Efficacy
- Abstract
Three coronavirus disease 2019 (COVID-19) vaccines have been authorized for use in the United States; specifically, the Pfizer-BioNTech, Moderna, and Johnson & Johnson-Janssen COVID-19 vaccines were granted emergency use authorization by the U.S. Food and Drug Administration in late 2020 and early 2021. Vaccination coverage and intent among adults are lowest among those aged 18-39 years and among females in particular. In females of reproductive age, enthusiasm for receiving a COVID-19 vaccine may be negatively affected by claims currently circulating widely on diverse social media platforms regarding the vaccines adversely affecting fertility and pregnancy. Yet it is important to note that these claims are anecdotal in nature and not supported by the available scientific evidence. It is also imperative that the effects of COVID-19 vaccine on reproductive health are clarified. Herein, we discuss the existing scientific data supporting COVID-19 vaccine safety and efficacy in people who are planning to conceive or who are pregnant or lactating and highlight the importance of COVID-19 vaccination in females of reproductive age., Competing Interests: Financial Disclosure The authors did not report any potential conflicts of interest., (Copyright © 2021 Written work prepared by employees of the Federal Government as part of their official duties is, under the U.S. Copyright Act, a “work of the United States Government” for which copyright protection under Title 17 of the United States Code is not available. As such, copyright does not extend to the contributions of employees of the Federal Government. Published by Wolters Kluwer Health, Inc.)
- Published
- 2022
- Full Text
- View/download PDF
206. Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic Population.
- Author
-
Cyprian FS, Suleman M, Abdelhafez I, Doudin A, Masud Danjuma M, Mir FA, Parray A, Yousaf Z, Siddiqui MYA, Abdelmajid A, Mulhim M, Al-Shokri S, Abukhattab M, Shaheen R, Elkord E, Al-Khal AL, Elzouki AN, and Girardi G
- Subjects
- Adult, Aged, COVID-19 complications, Cohort Studies, Female, Humans, Hypoalbuminemia mortality, Hypoalbuminemia virology, Lymphocyte Count, Lymphopenia mortality, Lymphopenia virology, Male, Middle Aged, Prognosis, Prospective Studies, Qatar, SARS-CoV-2, Biomarkers blood, COVID-19 blood, COVID-19 mortality, Complement C5a analysis, Patient Acuity
- Abstract
Coronavirus disease-2019 (COVID-19) was declared as a pandemic by WHO in March 2020. SARS-CoV-2 causes a wide range of illness from asymptomatic to life-threatening. There is an essential need to identify biomarkers to predict disease severity and mortality during the earlier stages of the disease, aiding treatment and allocation of resources to improve survival. The aim of this study was to identify at the time of SARS-COV-2 infection patients at high risk of developing severe disease associated with low survival using blood parameters, including inflammation and coagulation mediators, vital signs, and pre-existing comorbidities. This cohort included 89 multi-ethnic COVID-19 patients recruited between July 14
th and October 20th 2020 in Doha, Qatar. According to clinical severity, patients were grouped into severe (n=33), mild (n=33) and asymptomatic (n=23). Common routine tests such as complete blood count (CBC), glucose, electrolytes, liver and kidney function parameters and markers of inflammation, thrombosis and endothelial dysfunction including complement component split product C5a, Interleukin-6, ferritin and C-reactive protein were measured at the time COVID-19 infection was confirmed. Correlation tests suggest that C5a is a predictive marker of disease severity and mortality, in addition to 40 biological and physiological parameters that were found statistically significant between survivors and non-survivors. Survival analysis showed that high C5a levels, hypoalbuminemia, lymphopenia, elevated procalcitonin, neutrophilic leukocytosis, acute anemia along with increased acute kidney and hepatocellular injury markers were associated with a higher risk of death in COVID-19 patients. Altogether, we created a prognostic classification model, the CAL model (C5a, Albumin, and Lymphocyte count) to predict severity with significant accuracy. Stratification of patients using the CAL model could help in the identification of patients likely to develop severe symptoms in advance so that treatments can be targeted accordingly., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Cyprian, Suleman, Abdelhafez, Doudin, Masud Danjuma, Mir, Parray, Yousaf, Siddiqui, Abdelmajid, Mulhim, Al-Shokri, Abukhattab, Shaheen, Elkord, Al-khal, Elzouki and Girardi.)- Published
- 2021
- Full Text
- View/download PDF
207. Temporal preparation in adults with autistic spectrum disorder: The variable foreperiod effect.
- Author
-
Girardi G, Fernandez LG, Leboyer M, Latimier A, Chokron S, and Zalla T
- Subjects
- Adult, Attention, Cognition, Humans, Reaction Time, Autism Spectrum Disorder, Time Perception
- Abstract
Research suggested the possibility that temporal cognition may be different in autistic spectrum disorder (ASD). Although there are some empirical studies examining timing ability in these individuals, to our knowledge, no one directly assessed the ability to predict when an event will occur. Here, we report a study on implicit temporal preparation in individuals with ASD as indexed by the variable foreperiod (FP) effect. We compared a group of adult ASD participants to a group of typically-developed (TD) controls, for their respective abilities to utilize implicit temporal information in a simple detection task with three different preparatory intervals (FP, short, middle and long). Participants were given a warning tone to signal an imminent stimulus, and asked to press a key as quickly as they could upon detection of the stimulus. Both groups were able to use implicit temporal information, as revealed by both the variable-FP effect (i.e., faster response for targets appearing after a long FP) and asymmetric sequential effects (i.e., slower response in short-FP trials following a previous long-FP trial). The TD group exhibited a faster response in a long-FP trial that was preceded by short-FP one, whereas the ASD group did not, as reflected in their higher percentage of response omissions for a target that appeared later than in the previous trial. The reduced ability of ASD participants to modulate their responses under these conditions might reflect a difficulty in time-based monitoring of stimulus occurrence. LAY SUMMARY: Time-processing may be different in autistic spectrum disorder (ASD). This study addressed the ability to anticipate a relevant stimulus's onset according to predictable interstimulus intervals comparing adults with ASD and typically developed controls. We found that ASD participants did not benefit from temporal preparation when stimulus appeared later than previously attended. This suggests a reduced ability in detecting implicit temporal regularities between events., (© 2021 International Society for Autism Research and Wiley Periodicals LLC.)
- Published
- 2021
- Full Text
- View/download PDF
208. User-centered practices in the eyes of informal caregivers of in-patients with severe acquired brain injury: needs, caring experience, and satisfaction.
- Author
-
Girardi G, Farnese ML, Scarponi F, De Tanti A, Bartolo M, Intiso D, Formisano R, and Antonucci G
- Subjects
- Communication, Humans, Patient Satisfaction, Personal Satisfaction, Brain Injuries, Caregivers
- Abstract
Objective: This study examines the perceived needs, experience, and satisfaction of informal caregivers (ICGs) in in-hospital settings, related to their involvement in the design and delivery of services together with hospital staff, namely co-production., Design: To obtain a picture of current ICG-staff relationship, a multicenter observational study was carried out. Participants were 75 ICGs recruited in five dedicated in-patient neurorehabilitation wards. Participants answered a self-report questionnaire tapping perceived information/communication needs, emotional/social needs, and their satisfaction; family-centered practices implemented by the staff (namely involving practices and cooperative communication); and ICGs' satisfaction with the service., Results: Need satisfaction related positively to staff practices aimed at involving IGCs in treatment and training, but not in decision-making. Involving practices concerning treatment also related positively to ICGs' information/communication needs. In addition, the more the staff involved ICGs in decision-making and promoted cooperative communication regarding treatment, the more ICGs felt that their collaboration in the healthcare process was valuable. Finally, all involvement practices and cooperative communication were positively related to ICGs' overall satisfaction with the service., Conclusion: The results of the study help to identify gaps in meeting ICGs' needs and to promote strategies to implement family participation toward co-production in in-hospital settings.
- Published
- 2021
- Full Text
- View/download PDF
209. Pravastatin plus L-arginine prevents adverse pregnancy outcomes in women with uteroplacental vascular dysfunction.
- Author
-
Jurisic A, Jurisic Z, Lefkou E, and Girardi G
- Subjects
- Adult, Arginine adverse effects, Drug Therapy, Combination, Female, Fetal Growth Retardation diagnostic imaging, Fetal Growth Retardation physiopathology, Humans, Live Birth, Pilot Projects, Placental Insufficiency diagnostic imaging, Placental Insufficiency physiopathology, Pravastatin adverse effects, Pre-Eclampsia diagnosis, Pre-Eclampsia physiopathology, Pregnancy, Time Factors, Treatment Outcome, Ultrasonography, Doppler, Ultrasonography, Prenatal, Arginine therapeutic use, Fetal Growth Retardation drug therapy, Hemodynamics drug effects, Placental Circulation drug effects, Placental Insufficiency drug therapy, Pravastatin therapeutic use, Pre-Eclampsia prevention & control
- Abstract
Background: Uteroplacental vascular dysfunction, characterized by diminished uterine artery (UtA) blood flow in the second trimester is a clinically useful predictor of the further development of preeclampsia, fetal growth restriction and stillbirth. Efforts to develop effective treatments to protect pregnancies with abnormal UtA Dopplers would be of significant clinical benefit for mothers and their fetuses., Objective: The aim of this pilot non randomized control study was to use pravastatin +L-arginine to improve uteroplacental haemodynamics and prevent adverse maternal and neonatal outcomes in women with abnormal Dopplers and high risk for developing adverse pregnancy outcomes., Study Design: This study was performed between 2015 and 2018. All women received primary care at OB/GYN Polyclinic Jurisic and Narodni Front University Hospital, University of Belgrade Medical School, Serbia. Approval for investigational drug use was obtained and all women gave informed consent. 10 pregnant women with a poor obstetric history that developed uteroplacental dysfunction (UtA pulsatility index (PI) above the 95th percentile and notching) at 20.5 weeks IQR [17.7-22] gave consent to be treated daily with pravastatin (40 mg) and L-arginine (1.5 g) to improve placental blood flow and pregnancy outcomes. 5 women remained untreated after diagnosis at 21 weeks [20-22] (control group). Due to presence of risk factors for pregnancy complications, close maternal and fetal monitoring was undertaken in all patients. Doppler examinations were performed to monitor changes in placental vascular resistance and fetal well-being and growth., Results: PRAV+L-arginine improved uteroplacental haemodynamics, increased fetal growth and prevented early onset preeclampsia leading to delivery close to term (delivery date: median 38 weeks, IQR[36.5-39]) and appropriate weight for gestational age compared to controls, in which placental blood flow did not improve and 2 women developed severe early onset preeclampsia. Neonates from the control group were born preterm (25 weeks IQR[23.5-25]), growth restricted and spent several months at NICU. Two neonates died due to prematurity-associated complications. PRAV+L-arginine treatment prolonged pregnancies for 4.1 months, compared to 26 days in the untreated group, preventing neonatal complications associated with prematurity. The infants are now 1-3 years old and show normal growth and development., Conclusion: This study describes the successful management with pravastatin+L-arginine of 10 pregnant patients with uteroplacental vascular dysfunction and high risk of adverse maternal and fetal outcomes. A larger study is being organized to confirm these observations., (Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
210. Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism.
- Author
-
Lefkou E, Varoudi K, Pombo J, Jurisic A, Jurisic Z, Contento G, and Girardi G
- Subjects
- Adult, Animals, Anti-Inflammatory Agents, Non-Steroidal administration & dosage, Anticholesteremic Agents administration & dosage, Anticoagulants administration & dosage, Antiphospholipid Syndrome blood, Antiphospholipid Syndrome diagnostic imaging, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Fetal Growth Retardation blood, Fetal Growth Retardation diagnostic imaging, Fetal Growth Retardation drug therapy, Hemodynamics drug effects, Hemodynamics physiology, Humans, Mice, Mice, Inbred C57BL, Placenta blood supply, Placenta drug effects, Placenta metabolism, Pre-Eclampsia blood, Pre-Eclampsia diagnostic imaging, Pre-Eclampsia drug therapy, Pregnancy, Pregnancy Complications blood, Pregnancy Complications diagnostic imaging, Pregnancy Outcome, Antiphospholipid Syndrome drug therapy, Aspirin administration & dosage, Heparin, Low-Molecular-Weight administration & dosage, Nitric Oxide blood, Pravastatin administration & dosage, Pregnancy Complications drug therapy
- Abstract
Objectives: A previous pilot study showed that pravastatin supplementation improved pregnancy outcomes in women with obstetric antiphospholipid syndrome (OAPS) that developed placental insufficiency despite standard of care treatment low molecular weight heparin plus low dose aspirin (LMWH + LDA). In this study we investigated the mechanism behind the beneficial effects of the triple therapy LMWH + LDA + pravastatin in improving uteroplacental vascular function and reducing pregnancy complications in OAPS. We hypothesized that nitric oxide (NO) is involved in the vasculoprotective effects of the triple therapy. A mouse model of OAPS that resembles the clinical scenario was used to test this hypothesis., Methods: Eleven women with OAPS that developed preeclampsia (PE) and/or intrauterine growth restriction (IUGR) associated with uteroplacental vascular dysfunction despite treatment with LMWH + LDA participated in this study after given informed written consent. Seven women were supplemented with pravastatin at the time abnormal uterine artery Dopplers were detected and 4 remained on LMWH + LDA treatment only. Wire myography was used to identify the mechanisms underpinning the protective effects of the triple therapy in the mouse model of OAPS., Results: The triple therapy increased serum NO levels, diminished uteroplacental vessels resistance improving placental function and prolonged pregnancies compared to conventional treatment LMWH + LDA, leading to live births in women with OAPS. Comparable to the observations in women, the triple therapy protected pregnancies in OAPS-mice, increasing placental perfusion and pregnancy outcomes. A synergistic vasculoprotective effect of the triple therapy on uterine arteries and aorta was demonstrated in OAPS-mice. LMWH + LDA showed a partial protection on endothelial function. Addition of pravastatin increase eNOS synthesis, expression and activity/signaling leading to a significant increment in nitric oxide (NO) generation, resulting in improved placental vascular function and total protection of pregnancies., Conclusion: LMWH + LDA + PRAV increased serum NO levels and significantly improved placental haemodynamics and maternal and neonatal outcomes in women and mice with OAPS. A role for eNOS/NO in mediating the placental vasculoprotective effects in OAPS-mice was demonstrated, strengthening the concept that impaired NO production is a crucial mediator in the pathogenesis of OAPS and a potential target for pharmacological interventions. The efficacy of pravastatin supplementation should be confirmed in a larger clinical trial., (Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
211. Clinical Validation of a Multi-Biomarker Assay for the Evaluation of Chronic Pain Patients in a Cross-Sectional, Observational Study.
- Author
-
Amirdelfan K, Pope JE, Gunn J, Hill MM, Cotten BM, Beresh JE, Dobecki D, Miller N, Mehta P, Girardi G, and Deer TR
- Abstract
Introduction: Chronic pain assessment and post-treatment evaluation continues to be challenging due to a lack of validated, objective tools to measure patient outcomes. Validation of mechanistic pain biomarkers would allow clinicians to objectively identify abnormal biochemistry contributing to painful symptoms., Methods: We describe the clinical validation of a multi-biomarker assay with algorithmic analysis known as the Foundation Pain Index (FPI) in diverse cohorts of chronic pain patients in a prospective, cross-sectional, observational validation study. Levels of 11 urinary pain biomarkers were measured and tabulated using a proprietary algorithm to generate FPI scores for chronic pain subjects (N = 153) and age- and sex-matched pain-free controls (N = 334)., Results: FPI scores were significantly correlated with the 36-Item Short Form Health Survey (SF-36) scores among chronic pain subjects (P value < 0.015) and specific components of SF-36, including emotional well-being, limitations due to emotional problems, and general health (P value < 0.05). Area under ROC analysis (AUROC) revealed FPI to accurately distinguish biomarker profiles between pain-free and chronic pain cohorts (AUROC: 0.7490, P value < 0.0001) as well as the SF-36 scores between chronic pain subjects with low vs. high FPI scores (AUROC: 0.7715, P value < 0.01)., Conclusions: Our findings establish the validity and discriminatory power of a novel multi-biomarker test that evaluates the role of biochemistry in chronic pain and correlates with clinical assessments of patients. This test provides novel, reproducible, objective data which may pave the way for non-opioid therapeutic strategies to treat chronic pain.
- Published
- 2020
- Full Text
- View/download PDF
212. Estimation of direct costs of melanoma in the Veneto Region: a budget assessment and cost-consequence analysis.
- Author
-
Buja A, Sartor G, Scioni M, Girardi G, Vecchiato A, Bolzan M, Rebba V, Chiarion Sileni V, Palozzo AC, Montesco M, Del Fiore P, Baldo V, and Rossi CR
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Critical Pathways economics, Female, Health Care Costs, Health Expenditures, Humans, Incidence, Infant, Infant, Newborn, Italy epidemiology, Male, Melanoma epidemiology, Melanoma pathology, Middle Aged, Skin Neoplasms epidemiology, Skin Neoplasms pathology, Young Adult, Melanoma economics, Models, Economic, Skin Neoplasms economics
- Abstract
Background: While many evidence-based pathways have been introduced to drive quality improvements in cancer care, most of these do not include evidence about their affordability. The main aim of this study was to provide an estimation of the overall budget to cover all the needs of melanoma patients in Veneto Region, managed according to the clinical pathway defined by the Rete Oncologica Veneta. A second objective is to conduct a cost-consequence analysis, comparing two different treatments., Methods: A very detailed whole-disease model was developed describing the patient's pathway from diagnosis through the first year of follow-up. Each procedure involved in the model was associated with a likelihood measure and a cost. The model can be used to estimate the expected direct costs associated with melanoma., Results: We can observe that 0 and I stage, despite accounting for a huge percentage of new melanoma cases are characterized by a small percentage of the total costs. Stage III can be considered as the most expensive stage accounting for 54% of the total costs with a 12% of patients. Finally, the stage IV patients, although very few accounts for almost the 7% of the total costs. Regarding the cost-consequence analysis, it was estimated that the therapies introduced in 2016 led to an approximately 14% increase in the total costs., Conclusions: Modeling a clinical pathway with a high level of detail enables to identify the main sources of spending. The consequent analysis can thus help policymakers to plan the future resources allocation.
- Published
- 2020
- Full Text
- View/download PDF
213. Caregivers' engagement during in-hospital care of sABI's patients: Evaluation of informal co-production from the health providers' perspective.
- Author
-
Farnese ML, Girardi G, Fida R, Bivona U, Bartolo M, De Tanti A, Intiso D, Scarponi F, and Antonucci G
- Subjects
- Adult, Burnout, Professional epidemiology, Consumer Behavior, Female, Humans, Interpersonal Relations, Italy, Male, Middle Aged, Patient Participation, Attitude of Health Personnel, Caregivers psychology, Hospitalization
- Abstract
One of the challenges of providing healthcare services is to enhance its value (for patients, staff and the service) by integrating the informal caregivers into the care process, both concretely managing their patient's health conditions and treatment (co-executing) and participating in the whole healthcare process (co-planning). This study aims at exploring the co-production contribution to the healthcare process, analysing whether and how it is related to higher caregivers' satisfaction with service care and reduced staff burnout, in the eyes of the staff. It also investigated two possible factors supporting caregivers in their role of co-producers, namely relationship among staff and informal caregivers related to knowledge sharing (i.e. an ability determinant supporting co-production) and related to role social conflict (i.e. a willingness determinant reducing co-production). Results of a structural equation model on a sample of 119 healthcare providers employed by neurorehabilitation centers in Italy with severe acquired brain injury confirmed that knowledge sharing positively related with caregivers' co-executing and co-planning. Also, social role conflict was negatively related with co-executing but positively with co-planning. Furthermore, co-planning resulted in being unrelated to both outcomes, whereas co-executing was associated with caregivers' satisfaction, as measured by staff perceptions. Overall, our data provided initial empirical evidence supporting the ability of the determinant's contribution in allowing informal caregivers to assume an active role in both co-production domains. Furthermore, as expected, the role of conflict willingness determinant was found to be a hindering factor for co-executing but, conversely, a trigger for co-planning. This result should be considered more carefully in future studies., (© 2020 John Wiley & Sons Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
214. Cost-effectiveness of a melanoma screening programme using whole disease modelling.
- Author
-
Buja A, Rivera M, Girardi G, Vecchiato A, Rebba V, Pizzo E, Sileni VC, Palozzo AC, Montesco M, Zorzi M, Sartor G, Scioni M, Bolzan M, Fiore PD, Bonavina MG, Rugge M, Baldo V, and Rossi CR
- Subjects
- Adult, Humans, Incidence, Italy epidemiology, Markov Chains, Melanoma epidemiology, Melanoma prevention & control, Middle Aged, Quality-Adjusted Life Years, State Medicine, Cost-Benefit Analysis, Early Detection of Cancer economics, Melanoma diagnosis, Models, Economic
- Abstract
Objective: To assess the potential impact of a melanoma screening programme, compared with usual care, on direct costs and life expectancy in the era of targeted drugs and cancer immunotherapy., Methods: Using a Whole Disease Model approach, a Markov simulation model with a time horizon of 25 years was devised to analyse the cost-effectiveness of a one-time, general practitioner-based melanoma screening strategy in the population aged over 20, compared with no screening. The study considered the most up-to-date drug therapy and was conducted from the perspective of the Veneto regional healthcare system within the Italian National Health Service. Only direct costs were considered. Sensitivity analyses, both one-way and probabilistic, were performed to identify the parameters with the greatest impact on cost-effectiveness, and to assess the robustness of our model., Results: Over a 25-year time horizon, the screening intervention dominated usual care. The probabilistic sensitivity analyses confirmed the robustness of these findings. The key drivers of the model were the proportion of melanomas detected by the screening procedure and the adherence of the target population to the screening programme., Conclusions: The screening programme proved to be a dominant option compared with usual care. These findings should prompt serious consideration of the design and implementation of a regional or national melanoma screening strategy within a National Health Service.
- Published
- 2020
- Full Text
- View/download PDF
215. Potential causes of male and female infertility in Qatar.
- Author
-
Zauner G and Girardi G
- Subjects
- Culture, Female, Humans, Incidence, Infertility, Female etiology, Infertility, Male etiology, Islam, Male, Qatar epidemiology, Risk Factors, Sexual Behavior, Consanguinity, Infertility, Female epidemiology, Infertility, Male epidemiology
- Abstract
A steady decline in the fertility rate has been observed in Qatar during the past fifty years. Therefore, infertility is considered a national priority in Qatar, a pronatalist society. This review article summarises the potential causes of infertility that are particularly prevalent in the Qatari population. The high rate of consanguinity leading to genetic abnormalities, the high incidence of metabolic disease, environmental contamination due to the rapid urbanization and oil and natural gas extraction procedures are discussed. In addition, the particular lifestyle of the Qatari population and the influence of religion and culture on sexual and reproductive behavior in an Arab/Islamic society are considered. The active response of the state of Qatar in implementing ways to mitigate the effects of these factors to protect fertility are also presented., (Copyright © 2020 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
216. Health and health service usage outcomes of case management for patients with long-term conditions: a review of reviews.
- Author
-
Buja A, Francesconi P, Bellini I, Barletta V, Girardi G, Braga M, Cosentino M, Marvulli M, Baldo V, and Damiani G
- Subjects
- Health Services, Humans, Patient Satisfaction, Systematic Reviews as Topic, Case Management, Quality of Life
- Abstract
Objective: There have been plenty of articles published in recent decades on patient care in the form of case management (CM), but conclusions regarding health outcomes and costs have often been discordant. The objective of this study was to examine previous systematic reviews and meta-analyses with a view to assessing and pooling the overwhelming amount of data available on CM-based health outcomes and resource usage., Methods: We conducted a review of reviews of secondary studies (meta-analyses and systematic reviews) addressing the effectiveness of CM compared with usual care (or other organizational models) in adult (18+) with long-term conditions. PubMed, the Cochrane Database of Systematic Reviews, and the Database of Abstracts of Reviews of Effects (DARE) were searched from 2000 to the end of December 2017. The outcomes of interest are related to process of care, health measures, and resource usage., Results: Twenty-two articles were ultimately considered: 4 meta-analyses and 18 systematic reviews. There is strong evidence of CM increasing adherence to treatment guidelines and improving patient satisfaction, but none of the secondary studies considered demonstrated any effect on patient survival. Based on the available literature, there is contrasting evidence regarding all the other health outcomes, such as quality of life (QOL), clinical outcomes, and functional status. Good-quality secondary studies consistently found nothing to indicate that CM prompts any reduction in the use of hospital resources., Conclusion: The source of variability in the literature on the consistency of the evidence for most outcomes is unclear. It may stem from the heterogeneity of CM programs in terms of what their intervention entails, the populations targeted, and the tools used to measure the results. That said, there was consistently strong evidence of CM being associated with a greater adherence to treatment guidelines and higher patient satisfaction, but not with a longer survival or better use of hospital resources.
- Published
- 2020
- Full Text
- View/download PDF
217. Essential Role of Complement in Pregnancy: From Implantation to Parturition and Beyond.
- Author
-
Girardi G, Lingo JJ, Fleming SD, and Regal JF
- Subjects
- Complement System Proteins immunology, Female, Fetal Development immunology, Humans, Complement Activation immunology, Embryo Implantation immunology, Parturition immunology, Pregnancy immunology, Pregnancy Complications immunology
- Abstract
The complement cascade was identified over 100 years ago, yet investigation of its role in pregnancy remains an area of intense research. Complement inhibitors at the maternal-fetal interface prevent inappropriate complement activation to protect the fetus. However, this versatile proteolytic cascade also favorably influences numerous stages of pregnancy, including implantation, fetal development, and labor. Inappropriate complement activation in pregnancy can have adverse lifelong sequelae for both mother and child. This review summarizes the current understanding of complement activation during all stages of pregnancy. In addition, consequences of complement dysregulation during adverse pregnancy outcomes from miscarriage, preeclampsia, and pre-term birth are examined. Finally, future research directions into complement activation during pregnancy are considered., (Copyright © 2020 Girardi, Lingo, Fleming and Regal.)
- Published
- 2020
- Full Text
- View/download PDF
218. Efficacy of a Combined Treatment of Botulinum Toxin and Intensive Physiotherapy in Hereditary Spastic Paraplegia.
- Author
-
Paparella G, Vavla M, Bernardi L, Girardi G, Stefan C, and Martinuzzi A
- Abstract
Introduction: The Hereditary Spastic Paraplegia (HSP) is a heterogeneous group of neurodegenerative disorders characterized by progressive spasticity and lower limbs (LL) weakness. There is no treatment to cure or halt the disease, except for symptomatic therapy. The use of botulinum toxin type A (BoNT-A) is one of the primary treatment for focal spasticity. Physiotherapy (PT) can help in maintaining residual functioning. We performed a retrospective study to evaluate the effect of the combined BoNT-A and intensive PT in patients with HSP., Methods: Eighteen adult patients (50% females) with clinical diagnosis of HSP were recruited. Eleven patients had a genetic diagnosis of SPG4, 5, 7, 8, 11, 72. Patients were all autonomously deambulant or needed support. BoNT-A was injected in 36 LL in different spastic muscles under electromyographic guidance and followed by intensive PT sessions. Outcome measures included disease severity, motor functional measures, perceived pain self-report and quality of life. Assessments occurred at baseline, 1 and 3 months after BoNT-A injection., Results: Most inoculated muscles were hamstrings, rectus femoris and gastrocnemius. We observed an improvement in muscle tone, in the gait velocity and distance length. Spastic Paraplegia Rating Scale was significantly reduced after treatment, in addition to improving pain and quality of life. These results were riconfirmed in 3 months time., Conclusion: Our study indicates that combined treatment of BoNT-A and PT can lead to improvement of spasticity and quality of life in patients with HSP., (Copyright © 2020 Paparella, Vavla, Bernardi, Girardi, Stefan and Martinuzzi.)
- Published
- 2020
- Full Text
- View/download PDF
219. Optical Coherence Tomography in a Cohort of Genetically Defined Hereditary Spastic Paraplegia: A Brief Research Report.
- Author
-
Vavla M, Paparella G, Papayannis A, Pascuzzo R, Girardi G, Pellegrini F, Capello G, Prosdocimo G, and Martinuzzi A
- Abstract
Introduction: In-vivo objective documentation of pathological changes in neurodegenerative disease is a major aim to possibly improve our ability to monitor disease progression and response to treatment. Temporal thinning of the retinal nerve fiber layer (RNFL) thickness shown by spectral domain optical coherence tomography (SD-OCT) has been reported in association with the complex forms in hereditary spastic paraplegia (HSP). We performed an assessment of the RNFL thickness in a group of HSP patients, including a longitudinal follow-up in a subgroup. Our aim was to measure and compare the changes and correlate them to clinical progression. Materials and Methods: Twenty-three HSP patients were recruited and studied with the SD-OCT including papillary and macular scan by Spectralis. The clinical severity was assessed using the Spastic Paraplegia Rating Scale. Results: Thinning of the superior, nasal and inferior quadrants bilaterally were observed compared to the normative data in both pure and complicated forms, that were clearly pathological only in a proportion of cases. Thinning correlated with age and disease duration, but not with clinical severity. The longitudinal study ( n = 9) showed no significant change compared to the baseline data for the period of observation (mean 10.7 months). Conclusions: RFNL is frequently thinned in HSP with no specific recognizable pattern of quadrants involved and SPG types. The small sample size and the short follow-up time showed no clear progression. Although SD-OCT appraisal of RFNL deserves to be explored in neurodegenerative conditions, it might not be suitable for use as a biomarker in HSP as it appears not to be specific to this condition and can be a feature of aging., (Copyright © 2019 Vavla, Paparella, Papayannis, Pascuzzo, Girardi, Pellegrini, Capello, Prosdocimo and Martinuzzi.)
- Published
- 2019
- Full Text
- View/download PDF
220. Immunomodulatory Effects of Vitamin D in Pregnancy and Beyond.
- Author
-
Cyprian F, Lefkou E, Varoudi K, and Girardi G
- Subjects
- Autoimmune Diseases drug therapy, Female, Humans, Immunologic Factors therapeutic use, Pregnancy, Pregnancy Complications drug therapy, Vitamin D therapeutic use, Vitamin D Deficiency drug therapy, Vitamin D Deficiency immunology, Autoimmune Diseases immunology, Immunologic Factors immunology, Pregnancy Complications immunology, Vitamin D immunology
- Abstract
In addition to its role in calcium homeostasis and bone formation, a modulatory role of the active form of vitamin D on cells of the immune system, particularly T lymphocytes, has been described. The effects of vitamin D on the production and action of several cytokines has been intensively investigated in recent years. In this connection, deficiency of vitamin D has been associated with several autoimmune diseases, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), antiphospholipid syndrome (APS), Hashimoto Thyroiditis (HT), and multiple sclerosis (MS). In a successful pregnancy, the maternal immune response needs to adapt to accommodate the semiallogeneic fetus. Disturbances in maternal tolerance are implicated in infertility and pregnancy complications such as miscarriages (RM) and preeclampsia (PE). It is well-known that a subset of T lymphocytes, regulatory T cells (Tregs) exhibit potent suppressive activity, and have a crucial role in curtailing the destructive response of the immune system during pregnancy, and preventing autoimmune diseases. Interestingly, vitamin D deficiency is common in pregnant women, despite the widespread use of prenatal vitamins, and adverse pregnancy outcomes such as RM, PE, intrauterine growth restriction have been linked to hypovitaminosis D during pregnancy. Research has shown that autoimmune diseases have a significant prevalence within the female population, and women with autoimmune disorders are at higher risk for adverse pregnancy outcomes. Provocatively, dysregulation of T cells plays a crucial role in the pathogenesis of autoimmunity, and adverse pregnancy outcomes where these pathologies are also associated with vitamin D deficiency. This article reviews the immunomodulatory role of vitamin D in autoimmune diseases and pregnancy. In particular, we will describe the role of vitamin D from conception until delivery, including the health of the offspring. This review highlights an observational study where hypovitaminosis D was correlated with decreased fertility, increased disease activity, placental insufficiency, and preeclampsia in women with APS., (Copyright © 2019 Cyprian, Lefkou, Varoudi and Girardi.)
- Published
- 2019
- Full Text
- View/download PDF
221. Pravastatin and-L-arginine combination improves umbilical artery blood flow and neonatal outcomes in dichorionic twin pregnancies through an nitric oxide-dependent vasorelaxant effect.
- Author
-
Jurisic A, Jurisic Z, Lefkou E, Pombo J, and Girardi G
- Subjects
- Adult, Animals, Arginine adverse effects, Blood Flow Velocity drug effects, Drug Combinations, Female, Fetal Growth Retardation diagnostic imaging, Fetal Growth Retardation metabolism, Fetal Growth Retardation physiopathology, Gestational Age, Humans, In Vitro Techniques, Infant, Newborn, Infant, Premature, Live Birth, Mice, Inbred C57BL, Nitric Oxide metabolism, Nitric Oxide Synthase Type III metabolism, Pilot Projects, Pravastatin adverse effects, Pregnancy, Premature Birth, Treatment Outcome, Ultrasonography, Prenatal, Umbilical Arteries diagnostic imaging, Umbilical Arteries metabolism, Umbilical Arteries physiopathology, Vascular Resistance drug effects, Vasodilator Agents adverse effects, Arginine therapeutic use, Fetal Growth Retardation prevention & control, Pravastatin therapeutic use, Pregnancy, Twin, Twins, Dizygotic, Umbilical Arteries drug effects, Vasodilation drug effects, Vasodilator Agents therapeutic use
- Abstract
The increase in fetal and neonatal morbidity and mortality associated with twin pregnancies correlates with an increased risk of preterm delivery, low birth weight, and intrauterine growth restriction (IUGR). Although the pathogenesis of IUGR is unclear and thus management remains a major challenge, feto-placental blood vessels are compromised, and altered umbilical blood flow is observed. In this pilot observational study we investigated the effects of pravastatin plus l-arginine on umbilical artery (umb art) blood flow. Between 2013 and 2016, five women received daily doses l-arginine and pravastatin when an umb art pulsatility index above limits for gestational age was observed and concerns about selective growth restrictions arose. All patients showed selective absent or reversed end-diastolic umbilical artery Doppler flow (AREDV) associated with increased perinatal mortality. Pravastatin (PRAV) plus l-arginine (l-Arg) treatment diminished umb art resistance significantly and allowed pregnancy to continue. No signs of acidosis or hypoxia, normal cardiotocography tracing, normal fetal movement and fetal weight gain were observed in the twins that showed abnormal umb art Dopplers. All neonates were born around 33 weeks (median 33 weeks, IQR [31.4-33.0]), thus diminishing substantially the chances for any prematurity-associated adverse neonatal outcomes. The infants now show normal growth and development. In in vitro studies, pravastatin induced relaxation of aortic rings. Murine studies identified were performed to investigate the mechanism behind PRAV+L-Arg beneficial effects. A nitric oxide (NO)-dependent synergistic vasorelaxant effect of PRAV+L-Arg was demonstrated using aortic rings. Increased levels of placental NO and increased synthesis of eNOS in placental endothelial cells were observed in mice treated with PRAV+L-Arg compared to untreated mice and mice treated with PRAV- or L-Arg alone. This study suggests that PRAV plus L-Arg might be a good therapeutic option to improve blood flow in umbilical arteries prolonging pregnancy and improving pregnancy outcomes in twins. A RCT should be organized to confirm these results., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
222. High-resolution mass spectrometry metabolomics of grape chemical markers to reveal use of not-allowed varieties in the production of Amarone and Recioto wines.
- Author
-
De Rosso M, Mayr CM, Girardi G, Vedova AD, and Flamini R
- Subjects
- Biomarkers metabolism, Vitis metabolism, Biomarkers analysis, Mass Spectrometry, Metabolomics, Vitis chemistry, Wine analysis
- Abstract
Introduction: Grape varieties allowed to produce Amarone della Valpolicella and Recioto DOCG wines are strictly regulated by their disciplinary of production. These are Corvina Veronese and Corvinone grapes, to a lesser extent also Rondinella can be used. The use of other varieties, is not allowed., Objectives: To identify chemical markers suitable to reveal addition of two not allowed grape varieties to the Corvina/Corvinone blend, such as Primitivo or Negro Amaro., Methods: The identification of the secondary metabolites of the four grape varieties was conducted by high-resolution mass spectrometry (HRMS) metabolomics. By using the signals of these metabolites the indexes able to identify the presence of Primitivo or Negro Amaro grapes in the Corvina/Corvinone 1:1 blend were calculated., Results: Indexes of laricitrin (Lr), delphinidin (Dp), and petunidin (Pt) signals were effective to identify the use of 10% Primitivo, while α-terpineol pentosyl-hexoside and linalool pentosyl-hexoside reveal the presence of Negro Amaro in the grape blend., Conclusions: Varietal markers useful to detect the presence of Primitivo and Negro Amaro in the grape blend were identified by HRMS metabolomics, a method suitable to check the identity of grapes on arrival at the winery, as well as the fermenting musts. The effectiveness of the identified markers in the final wines have to be confirmed. Potentially, a similar approach can be used to reveal analogous frauds performed on other high-quality wines.
- Published
- 2018
- Full Text
- View/download PDF
223. Pravastatin therapy during preeclampsia prevents long-term adverse health effects in mice.
- Author
-
Garrett N, Pombo J, Umpierrez M, Clark JE, Simmons M, and Girardi G
- Subjects
- Animals, Cardiovascular Diseases pathology, Disease Models, Animal, Endothelin-1 metabolism, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Hypertension pathology, Male, Mice, Mice, Inbred C57BL, Placenta drug effects, Placenta metabolism, Pravastatin administration & dosage, Pre-Eclampsia physiopathology, Pre-Eclampsia veterinary, Pregnancy, Risk Factors, Vascular Remodeling, Cardiovascular Diseases prevention & control, Hypertension prevention & control, Pravastatin therapeutic use, Pre-Eclampsia drug therapy
- Abstract
Preeclampsia (PE), associates with long-term increased risk for cardiovascular disease in women, suggesting that PE is not an isolated disease of pregnancy. It is not known if increased risk for long-term diseases is due to PE-specific factors or to prepregnancy renal and cardiovascular risk factors. We used a mouse model in which a WT female with normal prepregnancy health develops PE to investigate if preeclampsia causes long-term cardiovascular consequences after pregnancy for mothers and offspring. Mothers exhibited endothelial dysfunction and hypertension after PE and had glomerular injury that not only persisted but deteriorated, leading to fibrosis. Left ventricular (LV) remodeling characterized by increased collagen deposition and MMP-9 expression and enlarged cardiomyocytes were also detected after PE. Increased LV internal wall thickness and mass, increased end diastolic and end systolic volumes, and increased stroke volume were observed after PE in the mothers. Placenta-derived bioactive factors that modulate vascular function, markers of metabolic disease, vasoconstrictor isoprostane-8, and proinflammatory mediators were increased in sera during and after a preeclamptic pregnancy in the mother. Offspring of PE mice developed endothelial dysfunction, hypertension, and signs of metabolic disease. Microglia activation was increased in the neonatal brains after PE, suggesting neurogenic hypertension in offspring. Prevention of placental insufficiency with pravastatin prevented PE-associated cardiovascular complications in both mothers and offspring. In conclusion, factors that develop during PE have long-term, cardiovascular effects in the mother and offspring independent of prepregnancy risk factors.
- Published
- 2018
- Full Text
- View/download PDF
224. Erratum for Drusano et al., "Dilution Factor of Quantitative Bacterial Cultures Obtained by Bronchoalveolar Lavage in Patients with Ventilator-Associated Bacterial Pneumonia".
- Author
-
Drusano GL, Corrado ML, Girardi G, Ellis-Grosse EJ, Wunderink RG, Donnelly H, Leeper KV, Brown M, Malek T, Hite RD, Ferrari M, Djureinovic D, Kollef MH, Mayfield L, Doyle A, Chastre J, Combes A, Walsh TJ, Dorizas K, Alnuaimat H, Morgan BE, Rello J, Mazo CA, Jones RN, Flamm RK, Woosley L, Ambrose PG, Bhavnani S, Rubino CM, Bulik CC, Louie A, Vicchiarelli M, and Berman C
- Published
- 2018
- Full Text
- View/download PDF
225. Physico-Chemical, Electrochemical and Structural Insights Into Poly(3,4-ethylenedioxythiophene) Grafted from Molecularly Engineered Multi-Walled Carbon Nanotube Surfaces.
- Author
-
Gatti T, Girardi G, Vicentini N, Brandiele R, Wirix M, Durante C, and Menna E
- Abstract
Composites of multi-walled carbon nanotubes (MWCNTs) and poly(3,4-ethylenedioxythiophene) (PEDOT) are attracting the attention of material scientists since more than a decade as potential next-generation optoelectronic materials for their peculiar features, arising from the combination of the intrinsic electrical, thermal and morphological properties of the two components. They are indeed a promising platform for the development of low-cost, portable and environmentally friendly electronic devices such as supercapacitors, sensors and actuators. Here a novel synthetic strategy for their preparation is envisaged, exploiting the possibility to covalently functionalize the external surface of MWCNTs with tailored molecular units, starting from which the growth of the conjugated polymer can be induced oxidatively. The approach demonstrates its value in being able to effectively promote the formation of PEDOT chains in direct contact with the surface of MWCNTs, differently from what results when the monomer is polymerized in the presence of the pristine carbon nanomaterial. In addition, significant differences are found in the physico-chemical properties and electrochemical behavior when MWCNT-PEDOT covalent composites are studied in comparison to a non-covalent analogue, here illustrated in detail. These evidences constitute a starting point for the future development of novel more finely tuned functional materials based on MWCNT-PEDOT composites, featuring the required optoelectronic properties to precisely target the desired application.
- Published
- 2018
- Full Text
- View/download PDF
226. Complement activation, a threat to pregnancy.
- Author
-
Girardi G
- Subjects
- Animals, Complement Activation genetics, Complement System Proteins genetics, Complement System Proteins metabolism, Female, Fetal Development genetics, Fetal Development immunology, Fetal Diseases diagnosis, Fetal Diseases etiology, Fetal Diseases metabolism, Humans, Placenta immunology, Placenta metabolism, Pregnancy, Pregnancy Complications diagnosis, Pregnancy Complications metabolism, Complement Activation immunology, Complement System Proteins immunology, Disease Susceptibility immunology, Pregnancy Complications etiology
- Abstract
Pregnancy poses a challenge for the immune systems of placental mammals. As fetal tissues are semi-allogeneic and alloantibodies that commonly develop in the mother, the fetus and the placenta might be subject to complement-mediated immune attack with the potential risk of adverse pregnancy outcomes. Here, I describe how the use of animal models was pivotal in demonstrating that complement inhibition at the fetomaternal interface is essential for a successful pregnancy. Studies in animals also helped the identification of uncontrolled complement activation as a crucial effector in the pathogenesis of recurrent miscarriages, intrauterine growth restriction, preeclampsia, and preterm birth. Clinical studies employing complement biomarkers in plasma and urine showed an association between dysregulation of the complement system and adverse pregnancy outcomes. A better understanding of the role of the complement system in pregnancy complications will allow a rational approach to manipulate its activation as a potential therapeutic strategy with the goal of protecting pregnancies and improving long-term outcomes for mother and child.
- Published
- 2018
- Full Text
- View/download PDF
227. Dilution Factor of Quantitative Bacterial Cultures Obtained by Bronchoalveolar Lavage in Patients with Ventilator-Associated Bacterial Pneumonia.
- Author
-
Drusano GL, Corrado ML, Girardi G, Ellis-Grosse EJ, Wunderink RG, Donnelly H, Leeper KV, Brown M, Malek T, Hite RD, Ferrari M, Djureinovic D, Kollef MH, Mayfield L, Doyle A, Chastre J, Combes A, Walsh TJ, Dorizas K, Alnuaimat H, Morgan BE, Rello J, Mazo CA, Jones RN, Flamm RK, Woosley L, Ambrose PG, Bhavnani S, Rubino CM, Bulik CC, Louie A, Vicchiarelli M, and Berman C
- Subjects
- Bacterial Load, Humans, Pneumonia, Bacterial drug therapy, Pneumonia, Ventilator-Associated drug therapy, Urea blood, Bacteriological Techniques methods, Bronchoalveolar Lavage Fluid microbiology, Pneumonia, Bacterial microbiology, Pneumonia, Ventilator-Associated microbiology, Urea analysis
- Abstract
Ventilator-associated bacterial pneumonia (VABP) is a difficult therapeutic problem. Considerable controversy exists regarding the optimal chemotherapy for this entity. The recent guidelines of the Infectious Diseases Society of America and the American Thoracic Society recommend a 7-day therapeutic course for VABP based on the balance of no negative impact on all-cause mortality, less resistance emergence, and fewer antibiotic treatment days, counterbalanced with a higher relapse rate for patients whose pathogen is a nonfermenter. The bacterial burden causing an infection has a substantial impact on treatment outcome and resistance selection. We describe the baseline bronchoalveolar lavage (BAL) fluid burden of organisms in suspected VABP patients screened for inclusion in a clinical trial. We measured the urea concentrations in plasma and BAL fluid to provide an index of the dilution of the bacterial and drug concentrations in the lung epithelial lining fluid introduced by the BAL procedure. We were then able to calculate the true bacterial burden as the diluted colony count times the dilution factor. The median dilution factor was 28.7, with the interquartile range (IQR) being 11.9 to 53.2. Median dilution factor-corrected colony counts were 6.18 log
10 (CFU/ml) [IQR, 5.43 to 6.46 log10 (CFU/ml)]. In a subset of patients, repeat BAL on day 5 showed a good stability of the dilution factor. We previously showed that large bacterial burdens reduce or stop bacterial killing by granulocytes. (This study has been registered at ClinicalTrials.gov under registration no. NCT01570192.)., (Copyright © 2017 American Society for Microbiology.)- Published
- 2017
- Full Text
- View/download PDF
228. Pravastatin to treat and prevent preeclampsia. Preclinical and clinical studies.
- Author
-
Girardi G
- Subjects
- Animals, Clinical Trials as Topic, Disease Models, Animal, Drug Evaluation, Preclinical, Female, Fetal Development, Humans, Mice, Placenta drug effects, Pravastatin pharmacology, Pregnancy, Anticholesteremic Agents therapeutic use, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Placenta physiology, Pravastatin therapeutic use, Pre-Eclampsia drug therapy
- Abstract
Pre-eclampsia is a disease of pregnancy affecting 5%-8% of all pregnancies and a leading cause of maternal and fetal mortality. Despite improvements in the diagnosis, there is no effective method for prevention and treatment. While studies in women are of critical importance, investigation of pathological mechanisms in pregnant women is necessarily limited, and the ability to establish cause and effect relationships, difficult. Mouse models have been instrumental in defining pathogenic mechanisms in preeclampsia and in the identification of pravastatin as a potential treatment to prevent pregnancy complications associated with placental dysfunction. Numerous epidemiological studies provided robust evidence demonstrating that pravastatin exposure during pregnancy does not affect fetal development. In addition, pravastatin is hydrophilic and has a limited passage through the placenta, diminishing any safety concerns. Several pilot studies suggest that pravastatin may be a good option to prevent and treat preeclampsia in women. While these studies are promising, the effectiveness of pravastatin to treat preeclampsia needs to be confirmed by randomized clinical trials., (Copyright © 2017 Elsevier B.V. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
229. Complement C5a is present in CSF of human newborns and is elevated in association with preterm birth.
- Author
-
Pataky R, Howie FA, Girardi G, and Boardman JP
- Subjects
- Case-Control Studies, Humans, Infant, Newborn, Complement C5a cerebrospinal fluid, Infant, Premature cerebrospinal fluid
- Abstract
Neuroinflammation contributes to developmental brain injury associated with preterm birth, but the mediators that drive it are incompletely understood. Previous studies have shown that complement C5a is present and injurious in the brains of foetal mice exposed to preterm labour. Here, we demonstrate that C5a is present in the cerebrospinal fluid of newborn human infants and that levels are elevated in those born preterm. The difference is not explained by systemic infection. Complement activation in the neonatal brain and its role as a potential therapeutic target in preterm brain injury warrant further study. Activation in the neonatal brain and its role as a potential therapeutic target for preterm brain injury warrants further study.
- Published
- 2017
- Full Text
- View/download PDF
230. Associative cueing of attention through implicit feature-location binding.
- Author
-
Girardi G and Nico D
- Subjects
- Adult, Female, Humans, Judgment, Male, Memory, Short-Term physiology, Neuropsychological Tests, Young Adult, Association Learning physiology, Attention physiology, Cues, Visual Perception physiology
- Abstract
In order to assess associative learning between two task-irrelevant features in cueing spatial attention, we devised a task in which participants have to make an identity comparison between two sequential visual stimuli. Unbeknownst to them, location of the second stimulus could be predicted by the colour of the first or a concurrent sound. Albeit unnecessary to perform the identity-matching judgment the predictive features thus provided an arbitrary association favouring the spatial anticipation of the second stimulus. A significant advantage was found with faster responses at predicted compared to non-predicted locations. Results clearly demonstrated an associative cueing of attention via a second-order arbitrary feature/location association but with a substantial discrepancy depending on the sensory modality of the predictive feature. With colour as predictive feature, significant advantages emerged only after the completion of three blocks of trials. On the contrary, sound affected responses from the first block of trials and significant advantages were manifest from the beginning of the second. The possible mechanisms underlying the associative cueing of attention in both conditions are discussed., (Copyright © 2017 Elsevier B.V. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
231. Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome.
- Author
-
Bertolaccini ML, Contento G, Lennen R, Sanna G, Blower PJ, Ma MT, Sunassee K, and Girardi G
- Subjects
- Adult, Animals, Antimalarials therapeutic use, Antiphospholipid Syndrome blood, Brain abnormalities, Brain embryology, Complement C3a analysis, Complement C5a analysis, Enzyme-Linked Immunosorbent Assay, Female, Humans, Male, Mice, Inbred C57BL, Middle Aged, Placenta blood supply, Pregnancy, Pregnancy Complications blood, Pregnancy Outcome, Treatment Outcome, Antiphospholipid Syndrome drug therapy, Brain drug effects, Complement Activation drug effects, Hydroxychloroquine therapeutic use, Placenta drug effects, Pregnancy Complications drug therapy
- Abstract
Placental ischemic disease and adverse pregnancy outcomes are frequently observed in patients with antiphospholipid syndrome (APS). Despite the administration of conventional antithrombotic treatment a significant number of women continue to experience adverse pregnancy outcomes, with uncertain prevention and management. Efforts to develop effective pharmacological strategies for refractory obstetric APS cases will be of significant clinical benefit for both mothers and fetuses. Although the antimalarial drug, hydroxychloroquine (HCQ) is increasingly used to treat pregnant women with APS, little is known about its efficacy and mechanism of action of HCQ. Because complement activation plays a crucial and causative role in placental ischemia and abnormal fetal brain development in APS we hypothesised that HCQ prevents these pregnancy complications through inhibition of complement activation. Using a mouse model of obstetric APS that closely resembles the clinical condition, we found that HCQ prevented fetal death and the placental metabolic changes -measured by proton magnetic resonance spectroscopy in APS-mice. Using
111 In labelled antiphospholipid antibodies (aPL) we identified the placenta and the fetal brain as the main organ targets in APS-mice. Using this same method, we found that HCQ does not inhibit aPL binding to tissues as was previously suggested from in vitro studies. While HCQ did not affect aPL binding to fetal brain it prevented fetal brain abnormal cortical development. HCQ prevented complement activation in vivo and in vitro. Complement C5a levels in serum samples from APS patients and APS-mice were lower after treatment with HCQ while the antibodies titres remained unchanged. HCQ prevented not only placental insufficiency but also abnormal fetal brain development in APS. By inhibiting complement activation, HCQ might also be an effective antithrombotic therapy., (Copyright © 2016 Elsevier Ltd. All rights reserved.)- Published
- 2016
- Full Text
- View/download PDF
232. Urinary congophilia in women with hypertensive disorders of pregnancy and preexisting proteinuria or hypertension.
- Author
-
McCarthy FP, Adetoba A, Gill C, Bramham K, Bertolaccini M, Burton GJ, Girardi G, Seed PT, Poston L, and Chappell LC
- Subjects
- Adult, Case-Control Studies, Chronic Disease, Coloring Agents, Congo Red, Female, Humans, Hypertension urine, Pregnancy, Proteinuria urine, Young Adult, Amyloidogenic Proteins urine, Lupus Nephritis urine, Pre-Eclampsia urine, Renal Insufficiency, Chronic urine
- Abstract
Background: Congophilia indicates the presence of amyloid protein, which is an aggregate of misfolded proteins, that is implicated in the pathophysiologic condition of preeclampsia. Recently, urinary congophilia has been proposed as a test for the diagnosis and prediction of preeclampsia., Objectives: The purpose of this study was to determine whether urine congophilia is present in a cohort of women with preeclampsia and in pregnant and nonpregnant women with renal disease., Study Design: With the use of a preeclampsia, chronic hypertension, renal disease, and systemic lupus erythematosus cohort, we analyzed urine samples from healthy pregnant control subjects (n = 31) and pregnant women with preeclampsia (n = 23), gestational hypertension (n = 10), chronic hypertension (n = 14), chronic kidney disease; n = 28), chronic kidney disease with superimposed preeclampsia (n = 5), and chronic hypertension and superimposed preeclampsia (n = 12). Samples from nonpregnant control subjects (n = 10) and nonpregnant women with either systemic lupus erythematosus with (n = 25) and without (n = 14) lupus nephritis were analyzed. For each sample, protein concentration was standardized before it was mixed with Congo Red, spotted to nitrocellulose membrane, and rinsed with methanol. The optical density of the residual Congo Red stain was determined; Congo red stain retention was calculated, and groups were compared with the use of the Mann-Whitney test or Kruskal-Wallis analysis of Variance test, as appropriate., Results: Congophilia was increased in urine from women with preeclampsia (median Congo red stain retention, 47%; interquartile range, 22-68%) compared with healthy pregnant control subjects (Congo red stain retention: 16%; interquartile range, 13-21%; P = .002), women with gestational hypertension (Congo red stain retention, 20%; interquartile range, 13-27%; P = .008), or women with chronic hypertension (Congo red stain retention, 17%; interquartile range, 12-28%; P = .01). There were no differences in Congo red retention between pregnant women with chronic hypertension and normal pregnant control subjects (Congo red stain retention, 17% [interquartile range, 12-28%] vs 16% [interquartile range, 13-21%], respectively; P = .72). Congophilia was present in pregnant women with chronic kidney disease (Congo red stain retention, 32%; interquartile range, 14-57%), being similar to values found in women with preeclampsia (P = .22) and for women with chronic kidney disease and superimposed preeclampsia (Congo red stain retention, 57%; [interquartile range, 29-71%; P = .18). Nonpregnant women with lupus nephritis had higher congophilia levels compared with nonpregnant female control subjects (Congo red stain retention, 38% [interquartile range, 17-73%] vs 9% [7-11%], respectively; P < .001) and nonpregnant women with systemic lupus erythematosus without nephritis (Congo red stain retention, 38% [interquartile range, 17-73%] vs 13% [interquartile range, 11-17%], respectively; P = .001). A significant positive correlation was observed between congophilia and protein:creatinine ratio (Spearman rank correlations, 0.702; 95% confidence interval, 0.618-0.770; P < .001)., Conclusion: This study confirms that women with preeclampsia and chronic kidney disease without preeclampsia have elevated urine congophilia levels compared with healthy pregnant women. Nonpregnant women with lupus nephritis also have elevated urine congophilia levels compared with healthy control subjects. An elevated Congo Red stain retention may not be able to differentiate between these conditions; further research is required to explore the use of congophilia in clinical practice., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
233. Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy.
- Author
-
Lefkou E, Mamopoulos A, Dagklis T, Vosnakis C, Rousso D, and Girardi G
- Subjects
- Adult, Endothelium metabolism, Enoxaparin administration & dosage, Female, Gestational Age, Hemodynamics, Heparin, Low-Molecular-Weight administration & dosage, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors administration & dosage, Pregnancy, Risk Factors, Tinzaparin, Uterine Artery pathology, Antiphospholipid Syndrome drug therapy, Fibrinolytic Agents therapeutic use, Pravastatin administration & dosage, Pregnancy Complications drug therapy, Pregnancy Outcome
- Abstract
Background: Administration of conventional antithrombotic treatment (low-dose aspirin plus low-molecular weight heparin [LDA+LMWH]) for obstetric antiphospholipid syndrome (APS) does not prevent life-threatening placenta insufficiency-associated complications such as preeclampsia (PE) and intrauterine growth restriction (IUGR) in 20% of patients. Statins have been linked to improved pregnancy outcomes in mouse models of PE and APS, possibly due to their protective effects on endothelium. Here, we investigated the use of pravastatin in LDA+LMWH-refractory APS in patients at an increased risk of adverse pregnancy outcomes., Methods: We studied 21 pregnant women with APS who developed PE and/or IUGR during treatment with LDA+LMWH. A control group of 10 patients received only LDA+LMWH. Eleven patients received pravastatin (20 mg/d) in addition to LDA+LMWH at the onset of PE and/or IUGR. Uteroplacental blood hemodynamics, progression of PE features (hypertension and proteinuria), and fetal/neonatal outcomes were evaluated., Results: In the control group, all deliveries occurred preterm and only 6 of 11 neonates survived. Of the 6 surviving neonates, 3 showed abnormal development. Patients who received both pravastatin and LDA+LMWH exhibited increased placental blood flow and improvements in PE features. These beneficial effects were observed as early as 10 days after pravastatin treatment onset. Pravastatin treatment combined with LDA+LMWH was also associated with live births that occurred close to full term in all patients., Conclusion: The present study suggests that pravastatin may improve pregnancy outcomes in women with refractory obstetric APS when taken at the onset of PE or IUGR until the end of pregnancy.
- Published
- 2016
- Full Text
- View/download PDF
234. MRI-based methods to detect placental and fetal brain abnormalities in utero.
- Author
-
Girardi G
- Subjects
- Animals, Female, Humans, Mice, Pregnancy, Antiphospholipid Syndrome diagnostic imaging, Brain abnormalities, Brain diagnostic imaging, Contrast Media pharmacology, Ferric Compounds pharmacology, Fetus abnormalities, Fetus diagnostic imaging, Magnetic Resonance Imaging methods, Nanoparticles, Placenta abnormalities, Placenta diagnostic imaging, Placental Insufficiency diagnostic imaging
- Abstract
There are very few methods for screening women for pregnancy complications. Identification of pregnancies at risk would be of enormous clinical significance as would influence decisions made about pregnancy management and delivery. Adverse pregnancy outcomes such as obstetric antiphospholipid syndrome (APS) and preterm birth (PTB), characterized by placental insufficiency and abnormal fetal brain development, in mice and humans have been associated with activation of inflammatory pathways, in particular the complement cascade. Recently, antibodies against C3 activation products conjugated with contrast agent ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles were used to detect non-invasively sites of inflammation within the placenta and the fetal brain in mouse models of APS and PTB. In utero, magnetic resonance imaging (MRI)-based detection of C3 deposition in the placenta in the APS model was associated with signs of placental insufficiency and intrauterine growth restriction. In both models, fetal brain C3 deposition was associated with cortical axonal cytoarchitecture disruption and increased neurodegeneration. Proton magnetic resonance spectroscopy ((1)H MRS), another non invasive method, is used to identify metabolic abnormalities to predict fetal brain abnormalities. This review describes the recent development of preclinical MRI-based methods for the detection of inflammatory markers of placental insufficiency and abnormal fetal brain development and metabolism to predict pregnancy outcomes., (Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
235. Timing the events of directional cueing.
- Author
-
Girardi G, Antonucci G, and Nico D
- Subjects
- Adolescent, Adult, Association Learning, Female, Fixation, Ocular, Humans, Male, Young Adult, Attention, Cues, Orientation, Pattern Recognition, Visual, Reaction Time, Spatial Learning, Time Perception
- Abstract
To explore the role of temporal context on voluntary orienting of attention, we submitted healthy participants to a spatial cueing task in which cue-target stimulus onset asynchronies (SOAs) were organized according to two-dimensional parameters: range and central value. Three ranges of SOAs organized around two central SOA values were presented to six groups of participants. Results showed a complex pattern of responses in terms of spatial validity (faster responses to correctly cued target) and preparatory effect (faster responses to longer SOAs). Responses to validly and neutrally cued targets were affected by the increase in SOA duration if the difference between longer and shorter SOA was large. On the contrary, responses to invalidly cued targets did not vary according to SOA manipulations. The observed pattern of cueing effects does not fit in the typical description of spatial attention working as a mandatory disengaging-shifting-engaging routine. In contrast, results rather suggest a mechanism based on the interaction between context sensitive top-down processes and bottom-up attentional processes.
- Published
- 2015
- Full Text
- View/download PDF
236. Imaging of activated complement using ultrasmall superparamagnetic iron oxide particles (USPIO)--conjugated vectors: an in vivo in utero non-invasive method to predict placental insufficiency and abnormal fetal brain development.
- Author
-
Girardi G, Fraser J, Lennen R, Vontell R, Jansen M, and Hutchison G
- Subjects
- Animals, Antibodies, Antiphospholipid, Antiphospholipid Syndrome diagnosis, Antiphospholipid Syndrome metabolism, Antiphospholipid Syndrome pathology, Anxiety physiopathology, Brain metabolism, Complement C3 metabolism, Contrast Media metabolism, Disease Models, Animal, Female, Ferric Compounds metabolism, Lipopolysaccharides, Liver metabolism, Mice, Inbred C57BL, Motor Activity physiology, Nanoparticles metabolism, Placenta metabolism, Placenta pathology, Placental Insufficiency metabolism, Pregnancy, Pregnancy Outcome, Brain embryology, Brain pathology, Magnetic Resonance Imaging methods, Placental Insufficiency diagnosis, Placental Insufficiency pathology
- Abstract
In the current study, we have developed a magnetic resonance imaging-based method for non-invasive detection of complement activation in placenta and foetal brain in vivo in utero. Using this method, we found that anti-complement C3-targeted ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles bind within the inflamed placenta and foetal brain cortical tissue, causing a shortening of the T2* relaxation time. We used two mouse models of pregnancy complications: a mouse model of obstetrics antiphospholipid syndrome (APS) and a mouse model of preterm birth (PTB). We found that detection of C3 deposition in the placenta in the APS model was associated with placental insufficiency characterised by increased oxidative stress, decreased vascular endothelial growth factor and placental growth factor levels and intrauterine growth restriction. We also found that foetal brain C3 deposition was associated with cortical axonal cytoarchitecture disruption and increased neurodegeneration in the mouse model of APS and in the PTB model. In the APS model, foetuses that showed increased C3 in their brains additionally expressed anxiety-related behaviour after birth. Importantly, USPIO did not affect pregnancy outcomes and liver function in the mother and the offspring, suggesting that this method may be useful for detecting complement activation in vivo in utero and predicting placental insufficiency and abnormal foetal neurodevelopment that leads to neuropsychiatric disorders.
- Published
- 2015
- Full Text
- View/download PDF
237. [Maternity during the climateric].
- Author
-
Girardi G and Zalzman D
- Subjects
- Female, Humans, Middle Aged, Bioethical Issues, Menopause psychology, Pregnancy psychology
- Abstract
The climacteric is the last stage of the evolving life of women between the fertile period and its completion. The climacteric process in every woman has different manifestations in relation to their own history, their health and culture to which they belong. Traditionally the menopause has been linked with depression; we today consider it as a vital crisis which brings new possibilities, including motherhood. The changes during the 20th century in the status of women, the increase in longevity and reproductive techniques suggest motherhood is possible beyond the limits imposed by biology.
- Published
- 2014
238. Statins prevent cervical remodeling, myometrial contractions and preterm labor through a mechanism that involves hemoxygenase-1 and complement inhibition.
- Author
-
Gonzalez JM, Pedroni SM, and Girardi G
- Subjects
- Adult, Animals, CD55 Antigens genetics, CD55 Antigens metabolism, Cervix Uteri metabolism, Cervix Uteri physiopathology, Complement C5a pharmacology, Connexin 43 genetics, Connexin 43 metabolism, Female, Gene Expression Regulation, Heme Oxygenase-1 metabolism, Humans, Lipopolysaccharides, Male, Metalloporphyrins pharmacology, Mice, Mice, Inbred C57BL, Myometrium metabolism, Myometrium physiopathology, Obstetric Labor, Premature chemically induced, Obstetric Labor, Premature genetics, Obstetric Labor, Premature metabolism, Pregnancy, Protoporphyrins pharmacology, Uterine Contraction drug effects, Cervix Uteri drug effects, Complement C5a antagonists & inhibitors, Enzyme Inhibitors pharmacology, Heme Oxygenase-1 genetics, Myometrium drug effects, Obstetric Labor, Premature prevention & control, Pravastatin pharmacology
- Abstract
Preterm birth (PTB) is a major public health problem, with a global prevalence of 9.6% and over a million annual neonatal deaths. In a mouse model of preterm labor (PTL) induced by intravaginal administration of a subclinical dose of lipopolysaccharide (LPS), we previously demonstrated that LPS ascends to the cervix, inducing complement activation, cervical remodeling and PTL. Here we show that complement activation also plays a role in myometrial contractions during PTL in this model. Increased levels of C5a were detected in the myometrium of LPS-treated mice but not in age-matched control or term myometrium. Human and mouse myometrium incubated with C5a showed increased frequency of contractions and expression of connexin 43, suggesting that C5a is an uterotonic molecule. Statins, which showed beneficial effects in preventing complement-mediated pregnancy complications, prevented cervical remodeling, myometrial contractions and PTL in the LPS model. The protective effects of statins in PTL were associated with increased synthesis, expression and activity of heme oxygenase (HO-1) in myometrium and cervix. Coadministration of HO-1 inhibitor tin-protoporphyrin-IX with pravastatin abrogated the protective effects of pravastatin on cervical remodeling and myometrial contractions leading to PTB. In addition, pravastatin inhibited complement activation in the cervix by increasing the synthesis and expression of complement inhibitor decay-accelerating factor. This study in mice suggests that statins might be useful to prevent PTL in humans. Clinical trials in humans are needed and if these results are confirmed, they may form the basis for a new clinical approach to prevent PTB., (© The Author 2014. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)
- Published
- 2014
- Full Text
- View/download PDF
239. Clinical improvement and successful pregnancy in a preeclamptic patient with antiphospholipid syndrome treated with pravastatin.
- Author
-
Lefkou E, Mamopoulos A, Fragakis N, Dagklis T, Vosnakis C, Nounopoulos E, Rousso D, and Girardi G
- Subjects
- Adult, Antiphospholipid Syndrome epidemiology, Blood Pressure drug effects, Blood Pressure physiology, Comorbidity, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors pharmacology, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Pravastatin pharmacology, Pre-Eclampsia epidemiology, Pregnancy, Pregnancy Complications epidemiology, Treatment Outcome, Antiphospholipid Syndrome drug therapy, Pravastatin therapeutic use, Pre-Eclampsia drug therapy, Pregnancy Complications drug therapy, Pregnancy Outcome
- Published
- 2014
- Full Text
- View/download PDF
240. Can statins prevent pregnancy complications?
- Author
-
Girardi G
- Subjects
- Animals, Cholesterol metabolism, Disease Models, Animal, Female, Humans, Pregnancy, Abortion, Habitual prevention & control, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Pre-Eclampsia prevention & control, Pregnancy Complications prevention & control
- Abstract
Statins are potent inhibitors of cholesterol biosynthesis. The beneficial effects of the statins in preventing cardiovascular diseases are not entirely due to cholesterol reduction. Numerous studies suggest that the benefits observed with statins may be mediated by pleiotropic effects that are cholesterol-independent. There is now compelling evidence that statin therapy may diminish inflammation and oxidative stress, increase angiogenesis, inhibit the coagulation cascade and protect the endothelium. Several animal studies demonstrated that statins prevent pregnancy complications such as recurrent miscarriages and preeclampsia. Epidemiological data collected to date suggest that statins are not major teratogens. Clinical trials should be performed to demonstrate the effectiveness of statins in preventing bad pregnancy outcomes in women. Some of these trials recently started. This article summarizes the numerous effects of statins that can contribute to the pregnancy protection observed in animal models., (Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
241. Children living near chipboard and wood industries are at an increased risk of hospitalization for respiratory diseases: a prospective study.
- Author
-
Marchetti P, Marcon A, Pesce G, Paolo G, Guarda L, Pironi V, Fracasso ME, Ricci P, and de Marco R
- Subjects
- Adolescent, Child, Child, Preschool, Female, Humans, Industry, Male, Prospective Studies, Hospitalization statistics & numerical data, Respiratory Tract Diseases epidemiology, Wood
- Abstract
Pollutants emitted from wood processing factories may be harmful to the health of the population. The aim of this prospective cohort study was to evaluate whether proximity to wood factories was associated with the risk of hospital admissions in children living in the Viadana district (Italy), where two big chipboard industries and other smaller wood factories (sawmills, multi-strata layer manufacturing) are located. In 2006, children (3-14 years) living in the Viadana district were surveyed through a parental questionnaire (n=3854), their home/school addresses were geocoded and the distances to the wood industries were calculated. Hospital discharge records for the years 2007-2009 were obtained. Cox proportional hazard regression models were used to estimate the association between hospitalization rates and distance to the factories, adjusting for sex, age, nationality, parents' education, exposure to passive smoking and reported traffic near home. During the 3-year follow-up, the risk of hospitalization for all diagnoses (Hospitalization Hazard Ratio, HHR=1.55; 95% CI: 1.24-1.95) and for respiratory diseases (HHR=1.80; 95% CI: 1.14-2.86) was greater in the children living close (<2 km) to the chipboard industries, with respect to the children who lived at ≥2 km from any wood factory. The children living close to the smaller wood factories were also at increased risk of hospitalization for respiratory diseases (HHR=1.74; 95% CI: 1.06-2.85). This study highlights a health problem for the children living close to chipboard and wood factories in the Viadana district. Further research should develop accurate exposure models based on objective measurements of air pollution in order to confirm these findings., (Copyright © 2013 Elsevier GmbH. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
242. Complement inhibition and statins prevent fetal brain cortical abnormalities in a mouse model of preterm birth.
- Author
-
Pedroni SM, Gonzalez JM, Wade J, Jansen MA, Serio A, Marshall I, Lennen RJ, and Girardi G
- Subjects
- Animals, Antibodies, Neutralizing pharmacology, Cells, Cultured, Cerebral Cortex abnormalities, Cerebral Cortex drug effects, Complement C5a antagonists & inhibitors, Complement C5a genetics, Female, Fetus, Gene Expression Regulation, Glutamic Acid metabolism, Humans, Infant, Newborn, Mice, Models, Animal, Neurons drug effects, Neurons pathology, Pravastatin pharmacology, Pregnancy, Premature Birth genetics, Premature Birth pathology, Receptor, Anaphylatoxin C5a deficiency, Receptor, Anaphylatoxin C5a genetics, Receptors, Glutamate genetics, Receptors, Glutamate metabolism, Signal Transduction, Simvastatin pharmacology, Cerebral Cortex metabolism, Complement Activation, Complement C5a metabolism, Neurons metabolism, Premature Birth metabolism
- Abstract
Premature babies are particularly vulnerable to brain injury. In this study we focus on cortical brain damage associated with long-term cognitive, behavioral, attentional or socialization deficits in children born preterm. Using a mouse model of preterm birth (PTB), we demonstrated that complement component C5a contributes to fetal cortical brain injury. Disruption of cortical dendritic and axonal cytoarchitecture was observed in PTB-mice. Fetuses deficient in C5aR (-/-) did not show cortical brain damage. Treatment with antibody anti-C5, that prevents generation of C5a, also prevented cortical fetal brain injury in PTB-mice. C5a also showed a detrimental effect on fetal cortical neuron development and survival in vitro. Increased glutamate release was observed in cortical neurons in culture exposed to C5a. Blockade of C5aR prevented glutamate increase and restored neurons dendritic and axonal growth and survival. Similarly, increased glutamate levels - measured by (1)HMRS - were observed in vivo in PTB-fetuses compared to age-matched controls. The blockade of glutamate receptors prevented C5a-induced abnormal growth and increased cell death in isolated fetal cortical neurons. Simvastatin and pravastatin prevented cortical fetal brain developmental and metabolic abnormalities -in vivo and in vitro. Neuroprotective effects of statins were mediated by Akt/PKB signaling pathways. This study shows that complement activation plays a crucial role in cortical fetal brain injury in PTL and suggests that complement inhibitors and statins might be good therapeutic options to improve neonatal outcomes in preterm birth., (© 2013.)
- Published
- 2014
- Full Text
- View/download PDF
243. Comparison of the mechanisms responsible for cervical remodeling in preterm and term labor.
- Author
-
Gonzalez JM, Romero R, and Girardi G
- Subjects
- Animals, Cervix Uteri drug effects, Cervix Uteri pathology, Disease Models, Animal, Female, Humans, Mice, Molecular Targeted Therapy, Obstetric Labor, Premature drug therapy, Pregnancy, Wound Healing, Cervix Uteri immunology, Complement System Proteins immunology, Labor, Obstetric immunology, Obstetric Labor, Premature immunology
- Abstract
Understanding the mechanisms of term and preterm cervical remodeling is essential to prevent prematurity. Is preterm cervical remodeling caused by the same mechanisms that cause cervical remodeling at term, and are these changes accelerated in time? This question has been pondered by obstetricians seeking strategies to prevent preterm labor for many years. Mice represent an informative model of preterm birth. Thus, in this review we discuss the recent findings from mouse models that identify and characterize the initiators and cellular effectors of cervical remodeling at term and preterm labor/delivery. These studies suggest that similarities and differences exist between term and preterm cervical remodeling. Complement is an initiator or mediator in preterm labor/delivery, but is not involved in the physiological process that leads to term delivery. Therefore, complememt constitutes a specific and selective target for potentially preventing preterm delivery, thus improving neonatal health., (Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
244. Cueing spatial attention through timing and probability.
- Author
-
Girardi G, Antonucci G, and Nico D
- Subjects
- Adult, Female, Humans, Male, Photic Stimulation, Probability, Reaction Time physiology, Attention physiology, Cues, Space Perception physiology
- Abstract
Even when focused on an effortful task we retain the ability to detect salient environmental information, and even irrelevant visual stimuli can be automatically detected. However, to which extent unattended information affects attentional control is not fully understood. Here we provide evidences of how the brain spontaneously organizes its cognitive resources by shifting attention between a selective-attending and a stimulus-driven modality within a single task. Using a spatial cueing paradigm we investigated the effect of cue-target asynchronies as a function of their probabilities of occurrence (i.e., relative frequency). Results show that this accessory information modulates attentional shifts. A valid spatial cue improved participants' performance as compared to an invalid one only in trials in which target onset was highly predictable because of its more robust occurrence. Conversely, cuing proved ineffective when spatial cue and target were associated according to a less frequent asynchrony. These patterns of response depended on asynchronies' probability and not on their duration. Our findings clearly demonstrate that through a fine decision-making, performed trial-by-trial, the brain utilizes implicit information to decide whether or not voluntarily shifting spatial attention. As if according to a cost-planning strategy, the cognitive effort of shifting attention depending on the cue is performed only when the expected advantages are higher. In a trade-off competition for cognitive resources, voluntary/automatic attending may thus be a more complex process than expected., (Copyright © 2011 Elsevier Ltd. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
245. Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss.
- Author
-
Cohen D, Buurma A, Goemaere NN, Girardi G, le Cessie S, Scherjon S, Bloemenkamp KW, de Heer E, Bruijn JA, and Bajema IM
- Subjects
- Adult, Animals, Antibodies, Antiphospholipid administration & dosage, Antiphospholipid Syndrome complications, Antiphospholipid Syndrome pathology, Biomarkers, Complement C1q deficiency, Complement C4 metabolism, Disease Models, Animal, Female, Fetal Death chemically induced, Gestational Age, Humans, Lupus Erythematosus, Systemic complications, Lupus Erythematosus, Systemic immunology, Lupus Erythematosus, Systemic pathology, Mice, Mice, Inbred C57BL, Mice, Knockout, Placenta immunology, Placenta metabolism, Placenta pathology, Pregnancy, Pregnancy Outcome, Antibodies, Antiphospholipid immunology, Antiphospholipid Syndrome immunology, Complement Activation immunology, Complement C1q immunology, Fetal Death immunology
- Abstract
Recurrent miscarriage, fetal growth restriction and intrauterine fetal death are frequently occurring complications of pregnancy in patients with systemic lupus erythaematosus (SLE) and antiphospholipid syndrome (APS). Murine models show that complement activation plays a pivotal role in antiphospholipid antibody-mediated pregnancy morbidity, but the exact pathways of complement activation and their potential role in human pregnancy are insufficiently understood. We hypothesized that the classical pathway would play a major role in inducing fetal loss. Pregnant C57BL/6 mice and mice deficient in C1q and factor D were injected with antiphospholipid antibodies or normal human IgG. Mouse placentas were subsequently stained with an anti-C4 antibody and anti-normal human IgG to determine the presence of classical complement activation and IgG binding. Findings in mice were validated in 88 human placentae from 83 women (SLE and APS cases versus controls), which were immunohistochemically stained for C4d, C1q, properdin and MBL. Staining patterns were compared to pregnancy outcome. In murine placentae of mice pretreated with antiphospholipid antibodies, increased C4 deposition was observed, which was associated with adverse fetal outcome but not with IgG binding. In humans, diffuse C4d staining at the feto-maternal interface was present almost exclusively in patients with SLE and/or APS (p < 0.001) and was related to intrauterine fetal death (p = 0.03). Our data show that presence of C4d in murine and human placentae is strongly related to adverse fetal outcome in the setting of SLE and APS. The excessive deposition of C4d supports the concept of severe autoantibody-mediated injury at the fetal-maternal interface. We suggest C4d as a potential biomarker of autoantibody-mediated fetal loss in SLE and APS., (Copyright © 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.)
- Published
- 2011
- Full Text
- View/download PDF
246. Role of complement component C1q in the onset of preeclampsia in mice.
- Author
-
Singh J, Ahmed A, and Girardi G
- Subjects
- Animals, Blood Pressure physiology, Cell Movement drug effects, Collagenases metabolism, Complement C1q deficiency, Complement C1q genetics, Female, Hydroxymethylglutaryl-CoA Reductase Inhibitors pharmacology, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Mice, Mice, Knockout, Placenta blood supply, Placenta metabolism, Pravastatin pharmacology, Pravastatin therapeutic use, Pre-Eclampsia metabolism, Pre-Eclampsia prevention & control, Pregnancy, Regional Blood Flow drug effects, Regional Blood Flow physiology, Trophoblasts cytology, Vascular Endothelial Growth Factor A metabolism, Vascular Endothelial Growth Factor Receptor-1 metabolism, Complement C1q physiology, Disease Models, Animal, Pre-Eclampsia physiopathology
- Abstract
Preeclampsia (PE) is a life-threatening, pregnancy-induced disease and a leading cause of maternal and fetal morbidity and mortality. Despite considerable research, the causes of PE remain unclear, and there is no effective treatment. Studies in animal models that resemble this complex pregnancy-related disorder may help to identify possible therapies for PE. Complement component C1q has an important role in trophoblast migration, spiral arteries remodeling, and normal placentation. Here we show that pregnant C1q-deficient (C1q(-/-)) mice recapitulate the key features of human PE: hypertension, albuminuria, endotheliosis, decreased placental vascular endothelial growth factor (VEGF) and elevated levels of soluble VEGF receptor 1 (sFlt-1) that correlate with increased fetal death. In addition, decreased blood flow and increased oxidative stress are observed in placentas from C1q(-/-) mice. Treatment of C1q(-/-) mice with pravastatin restored trophoblast invasiveness, placental blood flow, and angiogenic balance and, thus, prevented the onset of PE. Serum-soluble receptors for VEGF-1 levels were reduced and placental VEGF levels were significantly increased in C1q(-/-) mice treated with pravastatin compared with untreated C1q(-/-) mice (VEGF: 1067±171 versus 419±194 pg/mL; P<0.01). Pravastatin treatment reduced hypertension (change in mean arterial pressure: 1±1 versus 18±3 mm Hg in C1q(-/-) untreated mice), and albuminuria (of creatinine) was reduced from 820±175 to 117±45 μg/mg (both P<0.01). Renal damage and endothelial dysfunction were significantly attenuated with pravastatin. This model that highlights the causative role of impaired trophoblast invasion in the pathogenesis of PE allowed us to identify pravastatin as a good therapeutic option to prevent PE.
- Published
- 2011
- Full Text
- View/download PDF
247. Complement activation in animal and human pregnancies as a model for immunological recognition.
- Author
-
Girardi G, Prohászka Z, Bulla R, Tedesco F, and Scherjon S
- Subjects
- Abortion, Habitual immunology, Animals, Complement C1q immunology, Disease Models, Animal, Female, Fetal Growth Retardation immunology, Humans, Male, Maternal-Fetal Exchange immunology, Mice, Placentation immunology, Pre-Eclampsia immunology, Pregnancy, T-Lymphocytes immunology, Complement Activation, Models, Immunological
- Abstract
Pregnancy is a most intriguing feature of biology, not at least because of the need to regulate the maternal immune response against fetal antigens. The mammalian embryo expresses paternal antigens foreign to the mother's immune system and thus elicits an immune response that can lead to fetal rejection and bad pregnancy outcomes such as recurrent miscarriages and preeclampsia. More effective strategies to prevent these pregnancy complications should be forthcoming once the underlying pathophysiological mechanisms that are involved in fetal rejection are completely understood. Our goal in writing this review is to discuss the crucial role of the complement system as an effector mechanism in placental and fetal damage that leads to bad pregnancy outcomes. Important information about the role of excessive complement activation and bad pregnancy outcomes was obtained from animal models. That uncontrolled complement activation puts at risk the survival of the fetus was reported in mouse models of recurrent miscarriages and preeclampsia. Interestingly, several observations described in the mouse models were confirmed in humans. Increased circulating levels of complement proteins, and their activation fragments were found in patients with preeclampsia, recurrent miscarriages and intrauterine growth restriction. Studies performed in animals and humans demonstrated the deleterious effect of complement activation on pregnancy outcomes. However, we also described in this article the strategic role of complement component C1q in normal placentation. C1q deserves special consideration for its role in promoting trophoblast invasion of deciduas, a crucial step in normal placental development. In conclusion, in this review we discussed all the available results of basic and clinical studies on the role of the complement system in pregnancy to expand the understanding of the pathophysiology of pregnancy complications., (Copyright © 2011 Elsevier Ltd. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
248. Complement activation triggers metalloproteinases release inducing cervical remodeling and preterm birth in mice.
- Author
-
Gonzalez JM, Franzke CW, Yang F, Romero R, and Girardi G
- Subjects
- Animals, Complement Activation, Complement C3 metabolism, Complement C5 metabolism, Female, Inflammation, Lipopolysaccharides metabolism, Male, Matrix Metalloproteinase 9 metabolism, Mice, Mice, Inbred C57BL, Pregnancy, Pregnancy, Animal, Premature Birth metabolism, Premature Birth prevention & control, Cervix Uteri pathology, Metalloproteases metabolism
- Abstract
Inflammation is frequently linked to preterm delivery (PTD). Here, we tested the hypothesis that complement activation plays a role in cervical remodeling and PTD. We studied two mouse models of inflammation-induced PTD. The first model was induced by vaginal administration of lipopolysaccharide (LPS) and the second one by administration of progesterone antagonist RU486. Increased cervical C3 deposition and macrophages infiltration and increased serum C3adesArg and C5adesArg levels were observed in both models when compared to gestational age matched controls. A significant increase in collagen degradation, matrix metalloproteinase 9 (MMP-9) activity and tissue distensibility was observed in the cervix in both models. Mice deficient in complement receptor C5a did not show increased MMP-9 activity and cervical remodeling and did not deliver preterm in response to LPS or RU486, suggesting a role for C5aR in the cervical changes that precede PTD. In vitro studies show that macrophages release MMP-9 in response to C5a. Progesterone diminished the amount of C5aR on the macrophages surface, inhibited the release of MMP-9 and prevented PTD. In addition, macrophages depletion also prevented cervical remodeling and PTD in LPS-treated mice. Our studies show that C5a-C5aR interaction is required for MMP-9 release from macrophages, and the cervical remodeling that leads to PTD. Complement inhibition and supplementation with progesterone may be good therapeutic options to prevent this serious pregnancy complication., (Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
249. Role of tissue factor in pregnancy complications: crosstalk between coagulation and inflammation.
- Author
-
Girardi G
- Subjects
- Abortion, Habitual drug therapy, Animals, Anticholesteremic Agents therapeutic use, Complement Activation, Complement System Proteins immunology, Female, Humans, Inflammation blood, Inflammation drug therapy, Inflammation immunology, Mice, Pravastatin therapeutic use, Pre-Eclampsia drug therapy, Pregnancy, Abortion, Habitual blood, Abortion, Habitual immunology, Blood Coagulation, Pre-Eclampsia blood, Pre-Eclampsia immunology, Thromboplastin immunology
- Abstract
Bad pregnancy outcomes have been associated with increased activation of the coagulation cascade and inflammation, in particular the activation of the complement cascade. Recent studies have suggested that inflammatory processes modulate thrombogenic pathways and vice versa. We studied the cross-talk between the coagulation and the complement cascade in the pathogenesis of recurrent miscarriages and preeclampsia in mice. We identified tissue factor (TF) as a crucial mediator of fetal and placental damage in mouse models of recurrent miscarriages and preeclampsia. Increased TF expression increases the release of reactive oxygen species and antiangiogenic molecules from inflammatory cells inducing trophoblast damage and bad pregnancy outcomes. We also demonstrated that pravastatin, by downregulating TF expression, prevents miscarriages and the onset of preeclampsia in mice., (© 2011 Elsevier Ltd. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
250. Role of tissue factor in feto-maternal development: a xiphos.
- Author
-
Girardi G
- Subjects
- Animals, Female, Humans, Mice, Mice, Inbred CBA, Mice, Inbred DBA, Pre-Eclampsia physiopathology, Pregnancy, Pregnancy Outcome, Fetal Development physiology, Thromboplastin physiology
- Abstract
In this review, the dual role of tissue factor (TF) in pregnancy is described. On the one hand, TF is required for embryonic and placental development in a successful pregnancy, and on the other hand, pathologic expression of TF can lead to serious pregnancy complications in humans and mice. Human studies show increased TF levels in plasma, amniotic fluid and and/or placentas of abnormal pregnancies affected by miscarriages, preterm birth, or pre-eclampsia. Interestingly, using two mouse models, we found that blood-borne TF plays a crucial role in the pathogenesis of pregnancy complications. TF on neutrophils and monocytes is a critical mediator in trophoblast injury and embryo damage in pregnancy loss induced by antiphospholipid antibodies and in the antibody-independent CBA/J × DBA/2 model of miscarriages. Blockade of TF or genetic diminution prevented pregnancy complications, suggesting that TF may be a good target for therapy in patients with recurrent miscarriages, pregnancy loss, and pre-eclampsia. In addition, statins, which downregulate TF, may constitute a good therapeutic option for women with pregnancy complications. Clinical trials should be conducted to confirm these observations in women., (© 2011 International Society on Thrombosis and Haemostasis.)
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.